
Industry Partnerships & Commercialization
The Industry Partnerships and Commercialization (IP&C) Office at The Hospital for Sick Children (SickKids) champions the identification, development, and commercialization of cutting-edge health innovations from SickKids researchers, partnering with industry and investors to translate these innovations into impactful healthcare services and products worldwide.
Transforming SickKids Innovation into Global Health Impact
At IP&C, our team comprises individuals with deep scientific expertise and extensive experience in patenting, licensing, commercial transactions, and startup ventures.
We go beyond traditional tech transfer roles by assisting SickKids Innovators in de-risking their discoveries, maximizing their value, and aligning with investor interests.
Discover how we connect ideas, industry, and investors to create efficient pathways for commercializing research and technology developed at SickKids by watching our video!
Latest News
SickKids scientist Dr. Jean-Philippe Julien named one of Canada's Top 40 Under 40 Congratulations to Dr. Jean-Philippe Julien, one of our entrepreneurial scientists at The Hospital for Sick [...]
SickKids and U of T spinout PhenoTips raises $2.5 million in seed funding Genetics software start-up PhenoTips, a spinout from The Hospital for Sick Children (SickKids) [...]
Highlights from the Inaugural SickKids Innovation Showcase The Industry Partnerships and Commercialization (IP&C) office at The Hospital for Sick Children in Toronto (SickKids) hosted the first [...]